JPMorgan Reinstates Teva Pharma (TEVA) at Overweight
Tweet
Share
E-mailGet Alerts TEVA Hot Sheet
Price: $31.48 -3.32%
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
JPMorgan reinstated coverage on Teva Pharma (NYSE: TEVA) with an Overweight rating and a price target of $82.00 (prior $70.00).
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $69.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades YDUQS Participacoes SA (YDUQ3:BZ) to Overweight
- Grupo Bimbo SAB de CV (BIMBOA:MM) (GRBMF) PT Raised to Peso57 at JPMorgan
- JPMorgan Downgrades Anima Holding SA (ANIM3:BZ) to Neutral
Create E-mail Alert Related Categories
Analyst PT Change, New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
